[Clinical course of Helicobacter pylori associated chronic gastritis in post-eradicational period].
Results of a prospective cohort study of Helicobacter pylori associated chronic gastritis in posteradicational period have been analyzed in the paper. Different versions and prognostic markers in posteradicational period were identified. Curation algorithm for a patient with chronic gastritis after antihelicobacter therapy was suggested.
Livzan
M A
MA
Kononov
A V
AV
Mozgovoĭ
S I
SI
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D015331:Cohort Studies; D003627:Data Interpretation, Statistical; D005260:Female; D005756:Gastritis / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D016481:Helicobacter Infections / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D016480:Helicobacter pylori / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008297:Male; D011446:Prospective Studies; D064750:Rabeprazole; D016896:Treatment Outcome
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D064750:Rabeprazole